Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #201078 on Amarin Corp Plc (AMRN)
MedResCollab
07/11/19 1:04 PM
#201081 RE: ggwpq #201078
Remember Repatha, a far less safe and efficacious CVD drug with much more trial patient data, was approved in 6-month time without AC. Vascepa will be a far easier and quicker decision for the FDA. -ggwpq